The Effect Of Edaravone On The Level Of Consciousness

The Effect Of Edaravone On The Level Of Consciousness In Patients With Hypoxic Encephalopathy: A Randomized Clinical Trial Study.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20250123064496N1

Enrollment

Registered

2025-02-24

Start date

2025-02-19

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Encephalopathy. Other and unspecified encephalopathy

Interventions

Intervention 1: Intervention group: Treatment With Edarvone 30 Mg Twice A Day For 10 Days Plus Routine Supportive Treatments. Intervention 2: Control group: Administration Of Placebo Along With Routin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All patients with hypoxic encephalopathy Known Insensitivity To Edaravone

Exclusion criteria

Exclusion criteria: Patients With A History Of Sever Anaphylactic Shock

Design outcomes

Primary

Measure	Time frame
Level of Consciousness. Timepoint: Before, During, And After The Intervention. Method of measurement: Based on the Glasgow Coma Scale.	—

Secondary

Measure	Time frame
CT Scan findings. Timepoint: Before, During, And After The Intervention. Method of measurement: CT Scan.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSaeed Razmeh

Yasouj University of Medical Sciences

srazmeh@yahoo.com+98 74 3323 5153

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026